{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:51:57Z","timestamp":1776477117498,"version":"3.51.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:00:00Z","timestamp":1437609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s10384-015-0392-2","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T05:30:29Z","timestamp":1437543029000},"page":"325-334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bimatoprost 0.01\u00a0% for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting"],"prefix":"10.1007","volume":"59","author":[{"given":"Michael Scott","family":"Kook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Simonyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Ho","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan Yun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"issue":"Suppl 1","key":"392_CR1","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.survophthal.2003.12.019","volume":"49","author":"JS Cohen","year":"2004","unstructured":"Cohen JS, Gross RL, Cheetham JK, VanDenburgh AM, Bernstein P, Whitcup SM. Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension. Surv Ophthalmol. 2004;49(Suppl 1):S45\u201352.","journal-title":"Surv Ophthalmol"},{"key":"392_CR2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/bjo.2007.128454","volume":"92","author":"RD Williams","year":"2008","unstructured":"Williams RD, Cohen JS, Gross RL, Liu CC, Safyan E, Batoosingh AL. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4. Br J Ophthalmol. 2008;92:1387\u201392.","journal-title":"Br J Ophthalmol"},{"key":"392_CR3","first-page":"1229","volume":"51","author":"FA Adatia","year":"2005","unstructured":"Adatia FA, Damji KF. Chronic open-angle glaucoma. Review for primary care physicians. Can Fam Physician. 2005;51:1229\u201337.","journal-title":"Can Fam Physician"},{"key":"392_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/14728214.2011.563733","volume":"16","author":"A Bagnis","year":"2011","unstructured":"Bagnis A, Papadia M, Scotto R, Traverso CE. Current and emerging medical therapies in the treatment of glaucoma. Expert Opin Emerg Drugs. 2011;16:293\u2013307.","journal-title":"Expert Opin Emerg Drugs."},{"key":"392_CR5","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archopht.120.10.1286","volume":"120","author":"EJ Higginbotham","year":"2002","unstructured":"Higginbotham EJ, Schuman JS, Goldberg I, Gross RL, VanDenburgh AM, Chen K, et al. One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthalmol. 2002;120:1286\u201393.","journal-title":"Arch Ophthalmol"},{"key":"392_CR6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/IJG.0b013e3181666557","volume":"17","author":"F Aptel","year":"2008","unstructured":"Aptel F, Cucherat M, Denis P. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials. J Glaucoma. 2008;17:667\u201373.","journal-title":"J Glaucoma"},{"key":"392_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02850157","volume":"21","author":"ST Simmons","year":"2004","unstructured":"Simmons ST, Dirks MS, Noecker RJ. Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials. Adv Ther. 2004;21:247\u201362.","journal-title":"Adv Ther."},{"issue":"661\u201371","key":"392_CR8","first-page":"e1","volume":"149","author":"LJ Katz","year":"2010","unstructured":"Katz LJ, Cohen JS, Batoosingh AL, Felix C, Shu V, Schiffman RM. Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension. Am J Ophthalmol. 2010;149(661\u201371):e1.","journal-title":"Am J Ophthalmol"},{"key":"392_CR9","first-page":"2097","volume":"6","author":"DR Nixon","year":"2012","unstructured":"Nixon, Simonyi S, Bhogal M, Sigouin CS, Crichton AC, Discepola M, et al. An observational study of bimatoprost 0.01% in treatment-na\u00efve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial. Clin Ophthalmol. 2012;6:2097\u2013103.","journal-title":"Clin Ophthalmol."},{"key":"392_CR10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2147\/OPTH.S31330","volume":"6","author":"S Pfennigsdorf","year":"2012","unstructured":"Pfennigsdorf S, Ramez O, von Kistowski G, M\u00e4der B, Eschstruth P, Frob\u00f6se M, et al. Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension. Clin Ophthalmol. 2012;6:739\u201346.","journal-title":"Clin Ophthalmol."},{"key":"392_CR11","first-page":"1031","volume":"8","author":"AC Crichton","year":"2014","unstructured":"Crichton AC, Nixon, Simonyi S, Bhogal M, Sigouin CS, Discepola MJ, et al. An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan((R)) RC Early Analysis Review (CLEAR) trial. Clin Ophthalmol. 2014;8:1031\u20138.","journal-title":"Clin Ophthalmol"},{"key":"392_CR12","first-page":"1641","volume":"111","author":"A Iwase","year":"2004","unstructured":"Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004;111:1641\u20138.","journal-title":"Ophthalmology"},{"key":"392_CR13","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/bjo.2007.128819","volume":"92","author":"K Kawase","year":"2008","unstructured":"Kawase K, Tomidokoro A, Araie M, Iwase A, Yamamoto T. Ocular and systemic factors related to intraocular pressure in Japanese adults: the Tajimi study. Br J Ophthalmol. 2008;92:1175\u20139.","journal-title":"Br J Ophthalmol"},{"key":"392_CR14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ophtha.2010.10.016","volume":"118","author":"CS Kim","year":"2011","unstructured":"Kim CS, Seong GJ, Lee NH, Song KC. Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology. 2011;118:1024\u201330.","journal-title":"Ophthalmology"},{"key":"392_CR15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-2415-14-160","volume":"14","author":"KH Park","year":"2014","unstructured":"Park KH, Simonyi S, Kim CY, Sohn YH, Kook MS. Bimatoprost 0.01% in treatment-naive patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting. BMC Ophthalmol. 2014;14:160.","journal-title":"BMC Ophthalmol."},{"key":"392_CR16","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2147\/OPTH.S41885","volume":"7","author":"S Pfennigsdorf","year":"2013","unstructured":"Pfennigsdorf S, de Jong L, Makk S, Fournichot Y, Bron A, Morgan-Warren RJ, et al. A combined analysis of five observational studies evaluating the efficacy and tolerability of bimatoprost\/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension. Clin Ophthalmol. 2013;7:1219\u201325.","journal-title":"Clin Ophthalmol."},{"issue":"Suppl 4","key":"392_CR17","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1016\/S0039-6257(01)00219-3","volume":"45","author":"M Sherwood","year":"2001","unstructured":"Sherwood M. Brandt J.; for the Bimatoprost Study Groups 1 and 2. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol. 2001;45(Suppl 4):S361\u20138.","journal-title":"Surv Ophthalmol"},{"key":"392_CR18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0161-6420(01)00584-X","volume":"108","author":"JD Brandt","year":"2001","unstructured":"Brandt JD, VanDenburgh AM, Chen K, Whitcup SM, for the Bimatoprost Study Group 1. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trial. Ophthalmology. 2001;108:1023\u201331 (discussion 32).","journal-title":"Ophthalmology"},{"key":"392_CR19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/112067210901900312","volume":"19","author":"S Kurtz","year":"2009","unstructured":"Kurtz S, Mann O. Incidence of hyperemia associated with bimatoprost treatment in na\u00efve subjects and in subjects previously treated with latanoprost. Eur J Ophthalmol. 2009;19:400\u20133.","journal-title":"Eur J Ophthalmol"},{"key":"392_CR20","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2147\/OPTH.S14915","volume":"4","author":"ER Craven","year":"2010","unstructured":"Craven ER, Liu CC, Batoosingh A, Schiffman RM, Whitcup SM. A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprost. Clin Ophthalmol. 2010;4:1433\u201340.","journal-title":"Clin Ophthalmol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-015-0392-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-015-0392-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-015-0392-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T15:33:01Z","timestamp":1567006381000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-015-0392-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["392"],"URL":"https:\/\/doi.org\/10.1007\/s10384-015-0392-2","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,23]]}}}